4.5-STAR CMS RATING

Our Navitus MedicareRx Employer Group Waiver Plan (EGWP) has received a 4.5 out of 5 Overall Star Rating from the Centers for Medicare & Medicaid Services (CMS). This rating applies to plan year 2020.

On September 23, 2019

Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to An Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product
 

about this drug recall >
On September 5, 2019

Takeda Issues US Recall of NATPARA® (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate

about this drug recall >
On July 19, 2019

Bayer is voluntarily recalling two lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

about this drug recall >

 

This plan, Navitus MedicareRx (PDP), is offered by Navitus Health Solutions and underwritten by Dean Health Insurance, Inc., A Federally-Qualified Medicare Contracting Prescription Drug Plan.